PharmaMénta Aps: Financial statements 2023
CVR: 25615697
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PharmaMénta Aps (CVR 25615697) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,939,892 and a net result of DKK 6,168 compared with DKK 19,820 the year before. That is an increase of 12.8% compared with the year before. Equity in the 2023 report amounted to DKK 643,691. The solvency ratio was 3.4%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,939,892
- Profit/Loss
- DKK 6,168
- Equity
- DKK 643,691
- Total Assets
- DKK 18,841,950
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.9 mio. | 6 t. | 644 t. | 2 |
| 2022 | - | 1.7 mio. | 20 t. | 638 t. | 2 |
| 2021 | - | 2.7 mio. | 1.2 mio. | 918 t. | 2 |
| 2020 | - | 1.7 mio. | 395 t. | -325 t. | 3 |
| 2019 | - | -246 t. | -1.2 mio. | -720 t. | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PharmaMénta Aps has published its annual report for 2022. Gross profit came to DKK 1,719,778, and the net result was DKK 19,820.
About PharmaMénta Aps
PharmaMénta Aps is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2000. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named EUROPHARMA.VET.DK ApS and AGROBEST ApS. The management consists of Jimmi Javed Christensen Malik. The board consists of Lasse Hvingelby Kikkenborg (chair), Jimmi Javed Christensen Malik and Torben Hvingelby Pedersen. The company is owned by Torben Hvingelby Pedersen, LHK Holding Esbjerg ApS and JMINT Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 5,249,012 and a net result of DKK 2,364,968 compared with DKK 2,121,363 the year before. Equity in the 2025 report amounted to DKK 5,130,022.